live sessions
PDT:
Pacific Daylight Time
PDT:
Pacific Daylight Time
Sunday (March 9) Sessions
Live Now:
MAR9
8:30 AMto12:30 PMPDT
12:00 PMto5:00 PMPDT
Scott M. Hammer Workshop for New Investigators and Trainees
8:30 AM8:30 AM
Welcome and (Session Overview) for the Scott M. Hammer Workshop for New Investigators and Trainees
8:31 AM8:31 AM
Virology: State of the Art and Navigating Presentations at CROI 2025
Stuart J.D. Neil
King's College London, London, UK
9:10 AM9:10 AM
Immunology: State of the Art and Navigating Presentations at CROI 2025
Lishomwa Ndhlovu
Weill Cornell Medicine, New York, NY, USA
10:10 AM10:10 AM
Prevention of HIV and STIs: State of the Art and Navigating Presentations at CROI 2025
Susan P. Buchbinder
San Francisco Department of Public Health, San Francisco, CA, USA
10:50 AM10:50 AM
HIV Treatment and Complications of HIV Disease: State of the Art and Navigating Presentations at CROI 2025
Judith S. Currier
University of California Los Angeles, Los Angeles, CA, USA
11:50 AM11:50 AM
HIV Cure Research: State of the Art and Navigating Presentations at CROI 2025
Joseph J. Eron, Jr
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
12:20 PM12:20 PM
Message to New Investigators
MAR9
2:00 PMto4:00 PMPDT
12:00 PMto5:00 PMPDT
Frontiers in Laboratory Technologies
2:00 PM2:00 PM
2 - Breaking the HIV Capsid: Atomic Force Microscopy Visualization
Juan R. Perilla
University of Delaware, Newark, DE, USA
2:30 PM2:30 PM
3 - Advances in Single-Cell Multiomic Profiling and Its Use in Virology and Immunology
Alexander Marson
University of California San Francisco, San Francisco, CA, USA
3:00 PM3:00 PM
4 - Visualizing Tissues: State-of-the-Art Single-Cell 3D Spatial Transcriptomics
Nikolaus Rajewsky
Berlin Institute for Medical Systems Biology, Berlin, Germany
3:30 PM3:30 PM
5 - Advances in CRISPR-Cas Editing Methods and Their Use in Virology and Immunology
Angela R. Wahl
University of Alabama at Birmingham, Birmingham, AL, USA
MAR9
2:00 PMto4:00 PMPDT
12:00 PMto5:00 PMPDT
Case-Based Workshop on the Liver and Its Complications
2:00 PM2:00 PM
6 - Liver Steatosis: New Nomenclature, New Tests, and New Drugs
Mandana Khalili
University of California San Francisco, San Francisco, CA, USA
2:40 PM2:40 PM
7 - Hepatitis B in the Gray Zone: Personalizing Treatment and Monitoring
Paul Y. Kwo
Stanford University, Stanford, CA, USA
3:20 PM3:20 PM
8 - Liver Cancer Surveillance: Who, How, When, and For How Long
Fasiha Kanwal
Baylor College of Medicine, Houston, TX, USA
3:50 PM3:50 PM
Discussion with Audience Questions and Answers
MAR9
2:00 PMto4:00 PMPDT
12:00 PMto5:00 PMPDT
Clinical Trial Design and Analysis
2:00 PM2:00 PM
9 - Using Machine Learning to Focus HIV Prevention Interventions
Carlos S. Saldana
Emory University, Atlanta, GA, USA
2:40 PM2:40 PM
10 - HIV Prevention Efficacy Trial Design: Lessons From Recent Trials
Holly Janes
Fred Hutchinson Cancer Center, Seattle, WA, USA
3:20 PM3:20 PM
11 - How Much Is Enough: The Importance of Pharmacokinetic Targets
Paolo Denti
University of Cape Town, Cape Town, South Africa
MAR9
2:00 PMto4:00 PMPDT
12:00 PMto5:00 PMPDT
Workshop on Antiretroviral Therapy: Case-Based Panel Discussion
2:01 PM2:01 PM
12 - Case Presentations With Panel Discussion, Plus Questions and Answers From the Audience
Jose R. Arribas
Hospital La Paz Institute for Health Research, Madrid, Spain
2:01 PM2:01 PM
12 - Case Presentations With Panel Discussion, Plus Questions and Answers From the Audience
Rachel A. Bender Ignacio
University of Washington, Seattle, WA, USA
2:01 PM2:01 PM
12 - Case Presentations With Panel Discussion, Plus Questions and Answers From the Audience
Cecilia Kanyama
UNC Project, Lilongwe. Malawi
2:01 PM2:01 PM
12 - Case Presentations With Panel Discussion, Plus Questions and Answers From the Audience
Juan Sierra-Madero
Instituto Nacional de Ciencias Médicas y Nutricion Salvador Zubiran, Mexico City, Mexico
2:01 PM2:01 PM
12 - Case Presentations With Panel Discussion, Plus Questions and Answers From the Audience
Oana Sandulescu
Carol Davila University of Medicine and Pharmacy, București, Romania
5:00 PM5:00 PM
Welcome from the Conference Chair
Diane V. Havlir
University of California San Francisco, San Francisco, CA, USA
5:10 PM5:10 PM
Introduction to the Bernard Fields Lecture
Katharine J. Bar
University of Pennsylvania, Philadelphia, PA, USA
5:15 PM5:15 PM
13 - Bernard Fields Lecture: How Integration Site Analyses Inform HIV Pathogenesis, Persistence, and Gene Therapy
Frederic D. Bushman
University of Pennsylvania, Philadelphia, PA, USA
5:40 PM5:40 PM
Introduction to the Martin Delaney Presentation
Dawn Averitt
The Well Project, Women's Research Initiative on HIV/AIDS, South Strafford, VT, USA
5:45 PM5:45 PM
14 - Martin Delaney Presentation: 40+ Years of HIV: What’s Changed, What Hasn’t, What Shouldn’t, What Must
Rebecca Denison
Woman Organized to Respond to Life-threatening Diseases (WORLD), Berkeley, CA, USA
6:10 PM6:10 PM
Introduction to the N'Galy-Mann Lecture
Wafaa M. El-Sadr
ICAP at Columbia University, New York, NY, USA
6:15 PM6:15 PM
15 - N'Galy-Mann Lecture: When Science Alone is Not Enough: The Intersection of Drug Use, Public Health, and Policy
Adeeba Kamarulzaman
Monash University Malaysia, Kuala Lumpur, Malaysia
6:40 PM6:40 PM
Special Presentation by the San Francisco Gay Men's Chorus
6:59 PM6:59 PM
Opening Session Conclusion and Welcome to the Opening Reception
Nicolas Chomont
Université de Montréal, Montreal, Canada
10:30 PM10:30 PM
Test Presentation 1
TestFirstName 1 TestMiddleName 1 TestLastName 1
Institution 1
10:30 PM10:30 PM
Test Presentation 2
TestFirstName 1 TestMiddleName 1 TestLastName 1
Institution 1
10:30 PM10:30 PM
Test Presentation 1
TestFirstName 1 TestMiddleName 1 TestLastName 1
Institution 1
10:30 PM10:30 PM
Test Presentation 2
TestFirstName 1 TestMiddleName 1 TestLastName 1
Institution 1
Upcoming:
MAR9
8:30 AMto12:30 PMPDT
12:00 PMto5:00 PMPDT
Scott M. Hammer Workshop for New Investigators and Trainees
8:30 AM8:30 AM
Welcome and (Session Overview) for the Scott M. Hammer Workshop for New Investigators and Trainees
8:31 AM8:31 AM
Virology: State of the Art and Navigating Presentations at CROI 2025
Stuart J.D. Neil
King's College London, London, UK
9:10 AM9:10 AM
Immunology: State of the Art and Navigating Presentations at CROI 2025
Lishomwa Ndhlovu
Weill Cornell Medicine, New York, NY, USA
10:10 AM10:10 AM
Prevention of HIV and STIs: State of the Art and Navigating Presentations at CROI 2025
Susan P. Buchbinder
San Francisco Department of Public Health, San Francisco, CA, USA
10:50 AM10:50 AM
HIV Treatment and Complications of HIV Disease: State of the Art and Navigating Presentations at CROI 2025
Judith S. Currier
University of California Los Angeles, Los Angeles, CA, USA
11:50 AM11:50 AM
HIV Cure Research: State of the Art and Navigating Presentations at CROI 2025
Joseph J. Eron, Jr
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
12:20 PM12:20 PM
Message to New Investigators
MAR9
2:00 PMto4:00 PMPDT
12:00 PMto5:00 PMPDT
Frontiers in Laboratory Technologies
2:00 PM2:00 PM
2 - Breaking the HIV Capsid: Atomic Force Microscopy Visualization
Juan R. Perilla
University of Delaware, Newark, DE, USA
2:30 PM2:30 PM
3 - Advances in Single-Cell Multiomic Profiling and Its Use in Virology and Immunology
Alexander Marson
University of California San Francisco, San Francisco, CA, USA
3:00 PM3:00 PM
4 - Visualizing Tissues: State-of-the-Art Single-Cell 3D Spatial Transcriptomics
Nikolaus Rajewsky
Berlin Institute for Medical Systems Biology, Berlin, Germany
3:30 PM3:30 PM
5 - Advances in CRISPR-Cas Editing Methods and Their Use in Virology and Immunology
Angela R. Wahl
University of Alabama at Birmingham, Birmingham, AL, USA
MAR9
2:00 PMto4:00 PMPDT
12:00 PMto5:00 PMPDT
Case-Based Workshop on the Liver and Its Complications
2:00 PM2:00 PM
6 - Liver Steatosis: New Nomenclature, New Tests, and New Drugs
Mandana Khalili
University of California San Francisco, San Francisco, CA, USA
2:40 PM2:40 PM
7 - Hepatitis B in the Gray Zone: Personalizing Treatment and Monitoring
Paul Y. Kwo
Stanford University, Stanford, CA, USA
3:20 PM3:20 PM
8 - Liver Cancer Surveillance: Who, How, When, and For How Long
Fasiha Kanwal
Baylor College of Medicine, Houston, TX, USA
3:50 PM3:50 PM
Discussion with Audience Questions and Answers
MAR9
2:00 PMto4:00 PMPDT
12:00 PMto5:00 PMPDT
Clinical Trial Design and Analysis
2:00 PM2:00 PM
9 - Using Machine Learning to Focus HIV Prevention Interventions
Carlos S. Saldana
Emory University, Atlanta, GA, USA
2:40 PM2:40 PM
10 - HIV Prevention Efficacy Trial Design: Lessons From Recent Trials
Holly Janes
Fred Hutchinson Cancer Center, Seattle, WA, USA
3:20 PM3:20 PM
11 - How Much Is Enough: The Importance of Pharmacokinetic Targets
Paolo Denti
University of Cape Town, Cape Town, South Africa
MAR9
2:00 PMto4:00 PMPDT
12:00 PMto5:00 PMPDT
Workshop on Antiretroviral Therapy: Case-Based Panel Discussion
2:01 PM2:01 PM
12 - Case Presentations With Panel Discussion, Plus Questions and Answers From the Audience
Jose R. Arribas
Hospital La Paz Institute for Health Research, Madrid, Spain
2:01 PM2:01 PM
12 - Case Presentations With Panel Discussion, Plus Questions and Answers From the Audience
Rachel A. Bender Ignacio
University of Washington, Seattle, WA, USA
2:01 PM2:01 PM
12 - Case Presentations With Panel Discussion, Plus Questions and Answers From the Audience
Cecilia Kanyama
UNC Project, Lilongwe. Malawi
2:01 PM2:01 PM
12 - Case Presentations With Panel Discussion, Plus Questions and Answers From the Audience
Juan Sierra-Madero
Instituto Nacional de Ciencias Médicas y Nutricion Salvador Zubiran, Mexico City, Mexico
2:01 PM2:01 PM
12 - Case Presentations With Panel Discussion, Plus Questions and Answers From the Audience
Oana Sandulescu
Carol Davila University of Medicine and Pharmacy, București, Romania
MAR9
5:00 PMto7:00 PMPDT
12:00 PMto5:00 PMPDT
Opening Session
5:00 PM5:00 PM
Welcome from the Conference Chair
Diane V. Havlir
University of California San Francisco, San Francisco, CA, USA
5:10 PM5:10 PM
Introduction to the Bernard Fields Lecture
Katharine J. Bar
University of Pennsylvania, Philadelphia, PA, USA
5:15 PM5:15 PM
13 - Bernard Fields Lecture: How Integration Site Analyses Inform HIV Pathogenesis, Persistence, and Gene Therapy
Frederic D. Bushman
University of Pennsylvania, Philadelphia, PA, USA
5:40 PM5:40 PM
Introduction to the Martin Delaney Presentation
Dawn Averitt
The Well Project, Women's Research Initiative on HIV/AIDS, South Strafford, VT, USA
5:45 PM5:45 PM
14 - Martin Delaney Presentation: 40+ Years of HIV: What’s Changed, What Hasn’t, What Shouldn’t, What Must
Rebecca Denison
Woman Organized to Respond to Life-threatening Diseases (WORLD), Berkeley, CA, USA
6:10 PM6:10 PM
Introduction to the N'Galy-Mann Lecture
Wafaa M. El-Sadr
ICAP at Columbia University, New York, NY, USA
6:15 PM6:15 PM
15 - N'Galy-Mann Lecture: When Science Alone is Not Enough: The Intersection of Drug Use, Public Health, and Policy
Adeeba Kamarulzaman
Monash University Malaysia, Kuala Lumpur, Malaysia
6:40 PM6:40 PM
Special Presentation by the San Francisco Gay Men's Chorus
6:59 PM6:59 PM
Opening Session Conclusion and Welcome to the Opening Reception
Nicolas Chomont
Université de Montréal, Montreal, Canada
MAR9
10:30 PMto10:45 PMPDT
12:00 PMto5:00 PMPDT
Test Session 1
10:30 PM10:30 PM
Test Presentation 1
TestFirstName 1 TestMiddleName 1 TestLastName 1
Institution 1
10:30 PM10:30 PM
Test Presentation 2
TestFirstName 1 TestMiddleName 1 TestLastName 1
Institution 1
MAR9
10:30 PMto10:45 PMPDT
12:00 PMto5:00 PMPDT
Test Session 2
10:30 PM10:30 PM
Test Presentation 1
TestFirstName 1 TestMiddleName 1 TestLastName 1
Institution 1
10:30 PM10:30 PM
Test Presentation 2
TestFirstName 1 TestMiddleName 1 TestLastName 1
Institution 1
Previous:
MAR9
8:30 AMto12:30 PMPDT
12:00 PMto5:00 PMPDT
Scott M. Hammer Workshop for New Investigators and Trainees
8:30 AM8:30 AM
Welcome and (Session Overview) for the Scott M. Hammer Workshop for New Investigators and Trainees
8:31 AM8:31 AM
Virology: State of the Art and Navigating Presentations at CROI 2025
Stuart J.D. Neil
King's College London, London, UK
9:10 AM9:10 AM
Immunology: State of the Art and Navigating Presentations at CROI 2025
Lishomwa Ndhlovu
Weill Cornell Medicine, New York, NY, USA
10:10 AM10:10 AM
Prevention of HIV and STIs: State of the Art and Navigating Presentations at CROI 2025
Susan P. Buchbinder
San Francisco Department of Public Health, San Francisco, CA, USA
10:50 AM10:50 AM
HIV Treatment and Complications of HIV Disease: State of the Art and Navigating Presentations at CROI 2025
Judith S. Currier
University of California Los Angeles, Los Angeles, CA, USA
11:50 AM11:50 AM
HIV Cure Research: State of the Art and Navigating Presentations at CROI 2025
Joseph J. Eron, Jr
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
12:20 PM12:20 PM
Message to New Investigators
MAR9
2:00 PMto4:00 PMPDT
12:00 PMto5:00 PMPDT
Frontiers in Laboratory Technologies
2:00 PM2:00 PM
2 - Breaking the HIV Capsid: Atomic Force Microscopy Visualization
Juan R. Perilla
University of Delaware, Newark, DE, USA
2:30 PM2:30 PM
3 - Advances in Single-Cell Multiomic Profiling and Its Use in Virology and Immunology
Alexander Marson
University of California San Francisco, San Francisco, CA, USA
3:00 PM3:00 PM
4 - Visualizing Tissues: State-of-the-Art Single-Cell 3D Spatial Transcriptomics
Nikolaus Rajewsky
Berlin Institute for Medical Systems Biology, Berlin, Germany
3:30 PM3:30 PM
5 - Advances in CRISPR-Cas Editing Methods and Their Use in Virology and Immunology
Angela R. Wahl
University of Alabama at Birmingham, Birmingham, AL, USA
MAR9
2:00 PMto4:00 PMPDT
12:00 PMto5:00 PMPDT
Case-Based Workshop on the Liver and Its Complications
2:00 PM2:00 PM
6 - Liver Steatosis: New Nomenclature, New Tests, and New Drugs
Mandana Khalili
University of California San Francisco, San Francisco, CA, USA
2:40 PM2:40 PM
7 - Hepatitis B in the Gray Zone: Personalizing Treatment and Monitoring
Paul Y. Kwo
Stanford University, Stanford, CA, USA
3:20 PM3:20 PM
8 - Liver Cancer Surveillance: Who, How, When, and For How Long
Fasiha Kanwal
Baylor College of Medicine, Houston, TX, USA
3:50 PM3:50 PM
Discussion with Audience Questions and Answers
MAR9
2:00 PMto4:00 PMPDT
12:00 PMto5:00 PMPDT
Clinical Trial Design and Analysis
2:00 PM2:00 PM
9 - Using Machine Learning to Focus HIV Prevention Interventions
Carlos S. Saldana
Emory University, Atlanta, GA, USA
2:40 PM2:40 PM
10 - HIV Prevention Efficacy Trial Design: Lessons From Recent Trials
Holly Janes
Fred Hutchinson Cancer Center, Seattle, WA, USA
3:20 PM3:20 PM
11 - How Much Is Enough: The Importance of Pharmacokinetic Targets
Paolo Denti
University of Cape Town, Cape Town, South Africa
MAR9
2:00 PMto4:00 PMPDT
12:00 PMto5:00 PMPDT
Workshop on Antiretroviral Therapy: Case-Based Panel Discussion
2:01 PM2:01 PM
12 - Case Presentations With Panel Discussion, Plus Questions and Answers From the Audience
Jose R. Arribas
Hospital La Paz Institute for Health Research, Madrid, Spain
2:01 PM2:01 PM
12 - Case Presentations With Panel Discussion, Plus Questions and Answers From the Audience
Rachel A. Bender Ignacio
University of Washington, Seattle, WA, USA
2:01 PM2:01 PM
12 - Case Presentations With Panel Discussion, Plus Questions and Answers From the Audience
Cecilia Kanyama
UNC Project, Lilongwe. Malawi
2:01 PM2:01 PM
12 - Case Presentations With Panel Discussion, Plus Questions and Answers From the Audience
Juan Sierra-Madero
Instituto Nacional de Ciencias Médicas y Nutricion Salvador Zubiran, Mexico City, Mexico
2:01 PM2:01 PM
12 - Case Presentations With Panel Discussion, Plus Questions and Answers From the Audience
Oana Sandulescu
Carol Davila University of Medicine and Pharmacy, București, Romania
MAR9
5:00 PMto7:00 PMPDT
12:00 PMto5:00 PMPDT
Opening Session
5:00 PM5:00 PM
Welcome from the Conference Chair
Diane V. Havlir
University of California San Francisco, San Francisco, CA, USA
5:10 PM5:10 PM
Introduction to the Bernard Fields Lecture
Katharine J. Bar
University of Pennsylvania, Philadelphia, PA, USA
5:15 PM5:15 PM
13 - Bernard Fields Lecture: How Integration Site Analyses Inform HIV Pathogenesis, Persistence, and Gene Therapy
Frederic D. Bushman
University of Pennsylvania, Philadelphia, PA, USA
5:40 PM5:40 PM
Introduction to the Martin Delaney Presentation
Dawn Averitt
The Well Project, Women's Research Initiative on HIV/AIDS, South Strafford, VT, USA
5:45 PM5:45 PM
14 - Martin Delaney Presentation: 40+ Years of HIV: What’s Changed, What Hasn’t, What Shouldn’t, What Must
Rebecca Denison
Woman Organized to Respond to Life-threatening Diseases (WORLD), Berkeley, CA, USA
6:10 PM6:10 PM
Introduction to the N'Galy-Mann Lecture
Wafaa M. El-Sadr
ICAP at Columbia University, New York, NY, USA
6:15 PM6:15 PM
15 - N'Galy-Mann Lecture: When Science Alone is Not Enough: The Intersection of Drug Use, Public Health, and Policy
Adeeba Kamarulzaman
Monash University Malaysia, Kuala Lumpur, Malaysia
6:40 PM6:40 PM
Special Presentation by the San Francisco Gay Men's Chorus
6:59 PM6:59 PM
Opening Session Conclusion and Welcome to the Opening Reception
Nicolas Chomont
Université de Montréal, Montreal, Canada
MAR9
10:30 PMto10:45 PMPDT
12:00 PMto5:00 PMPDT
Test Session 1
10:30 PM10:30 PM
Test Presentation 1
TestFirstName 1 TestMiddleName 1 TestLastName 1
Institution 1
10:30 PM10:30 PM
Test Presentation 2
TestFirstName 1 TestMiddleName 1 TestLastName 1
Institution 1
MAR9
10:30 PMto10:45 PMPDT
12:00 PMto5:00 PMPDT
Test Session 2
10:30 PM10:30 PM
Test Presentation 1
TestFirstName 1 TestMiddleName 1 TestLastName 1
Institution 1
10:30 PM10:30 PM
Test Presentation 2
TestFirstName 1 TestMiddleName 1 TestLastName 1
Institution 1
